ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Basic Aromatherapy to Help Balance and Calm

Tea drinkers have lower glaucoma risk

Wonderful White Tea: A Drink Fit for an Emperor

The Long-Term Benefits of Drinking Oolong Tea

Why You Should Try This Sweet-Smelling and Health-Boosting Essential Oil

Chamomile Tea: Why This Ancient Therapeutic Drink Still Stands Out Today

Arnica: This Powerful Herb Promotes Various Kinds of Healing

Get ‘Hooked’ on Cat’s Claw: The Many Benefits of This Amazonian Herb

Acid Reflux May Respond Better to Foods Than Prescribed Pills

Try Apple Cider Vinegar and Black Cumin Oil as Your Go-To Salad Dressing

Print Page
Email Article

Study: Most Lydonville Children Report At Least Mild Improvement

  [ 48 votes ]   [ Discuss This Article ]
By Mark Giuliucci • • November 28, 2001

Editor’s Note: The following article is reprinted with permission from The CFIDS Chronicle, Vol. 14 No. 3 Summer 2001.

Seventeen years ago, an unexplained epidemic struck the small upstate town of Lyndonville, N.Y. More than 200 people developed long-term, severe fatigue and a host of other physical problems. Doctors found no cause for the illness and discovered no cure. To this day, many of those stricken by the mystery ailment still feel the effects.

Now, a follow-up study of 35 children affected during the outbreak confirms that they were suffering from chronic fatigue and immune dysfunction syndrome (CFIDS). The study also says that 80 percent of the children surveyed said they had either fully recovered or had made some improvement.

The results were published in the May 2001 issue of the journal Pediatrics.

“There is some good news here,” says David S. Bell, MD, FAAP, co-author of the study. But Bell, who cared for all of the children during the outbreak in the 1980s, warns that the results aren’t completely positive. Many of the children who reported improvement, he says, have been forced to adapt their lifestyles to deal with lingering fatigue. And a significant percentage of the rest have shown little or no improvement since falling ill.

Bell, Karen Jordan, PhD, and Mary Robinson, MS, sent detailed health questionnaires to the 46 children and adolescents who were stricken during the Lyndonville outbreak between 1984 and 1987. Thirty-five of the children responded, 24 females and 11 males.

As children, all of those who returned the surveys would have met the current guidelines for CFIDS, which had not been created in the 1980s. None of the respondents had ever developed other diseases that would have explained their fatigue. The children were ages 5-18 when they first developed CFIDS symptoms.

Thirteen of the 35 patients who responded to the survey said they “recovered completely and feel entirely well” since first falling ill. Another 15 said they “never recovered completely but feel pretty well.” Four said they “recovered somewhat but remain ill,” and the other three said they were more ill than they were 10 years ago.

Bell says parents of children with CFIDS should find cause for optimism from the fact that so many of the Lydonville respondents said they had improved over the years. But he warns that fewer than half of those children claimed to be fully recovered. “The other half have simply learned to adapt,” Bell says. “There is a very big difference between the two groups.”

Meanwhile, the other 20 percent of respondents are “doing terribly,” Bell says. “Their lives have been totally disrupted.”

Predicting which children will improve over time is still not possible. But Bell says the survey results found a few factors that may play a role. The most important predictor was the amount of school that the children missed during the first years of their illness. In general, those who missed the most school days tended to fare the worst over time.

This could mean that those who develop severe early onset of CFIDS symptoms could be at higher risk than those whose symptoms worsened over time, Bell says.

Children who showed some improvement during the first three years of their illness also tended to make greater long-term gains than those who stayed the same or got worse during the same period. In addition, those children who developed severe neurological symptoms, such as brain inflammation (encephalitis), during the first year of their illness had poorer outcomes over time.

Bell stresses that these are overall trends, and do not apply in every case. He also says that it remains unknown whether the improvement rates in cluster outbreaks like the one in Lyndonville will differ from the rates in individual, non-outbreak cases.

Finally, Bell says that recovery seems to have little to do with the attending physician’s empathy with the patients. Ten of the 35 children surveyed had been patients of Bell for more than 10 years, while the rest had not seen him since the early years of their illness. There was no significant difference in the rates of recovery between the two groups. Bell says this should help refute claims that children with CFIDS complain more about symptoms if they have a sympathetic ear from their doctor.

Overall, 80 percent of the children who responded to the survey said that their illness had little or no effect on their social lives. The other 20 percent reported a moderate to severe impact socially. In general, these reports coincided with the reports of overall recover rates. Of the 12 children who claimed no social effect, 10 also said they had fully recovered from their CFIDS symptoms.

Reference: David S. Bell, MD, FAAP; Karen Jordan, PhD; and Mary Robinson, MS. “Thirteen-Year Follow-Up of Children and Adolescents With Chronic Fatigue Syndrome.” Pediatrics. 2001.107(5): 994-998.

Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Mitochondria Ignite™ with NT Factor® Energy NADH™ 12.5mg

Article Comments

Be the first to comment on this article!

Post a Comment

Optimized Curcumin Longvida with Omega-3

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

The Genetic Mutation That May Compromise Your Health - And What to Do About It The Genetic Mutation That May Compromise Your Health - And What to Do About It
Running on Empty? Fuel Up with NADH Running on Empty? Fuel Up with NADH
The Guaifenesin Story: A centuries-old bark extract used for clearing the airways – now key to a popular FM symptom-reversal protocol The Guaifenesin Story: A centuries-old bark extract used for clearing the airways – now key to a popular FM symptom-reversal protocol
The New Dual Activation Pain Relief Cream The New Dual Activation Pain Relief Cream
Front Line Defense Against Colds & Flu - Support for Healthy Immune System Balance Front Line Defense Against Colds & Flu - Support for Healthy Immune System Balance

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2018 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map